The State of Texas Attorney General Takes Legal Action Against Tylenol Makers Concerning Autism Assertions

Courtroom Proceedings
The Texas Attorney General, who supports former President Trump campaigning for US Senate, accused pharmaceutical manufacturers of concealing safety concerns of Tylenol

The top legal official in Texas Ken Paxton is taking legal action against the makers of acetaminophen, claiming the corporations hid safety concerns that the pain reliever posed to children's brain development.

This legal action follows a month after President Donald Trump publicized an unverified association between taking Tylenol - alternatively called acetaminophen - throughout gestation and autism spectrum disorder in children.

Paxton is filing suit against the pharmaceutical giant, which previously sold the drug, the exclusive pain medication recommended for women during pregnancy, and the current manufacturer, which now manufacturers it.

In a official comment, he claimed they "misled consumers by making money from discomfort and pushing pills ignoring the potential hazards."

The manufacturer says there is no credible evidence tying Tylenol to autism spectrum disorder.

"These corporations deceived for years, intentionally threatening millions to boost earnings," the attorney general, from the Republican party, stated.

The company said in a statement that it was "deeply concerned by the perpetuation of misinformation on the security of acetaminophen and the possible consequences that could have on the health of American women and children."

On its online platform, the company also mentioned it had "regularly reviewed the pertinent research and there is insufficient valid information that demonstrates a established connection between using acetaminophen and autism."

Associations representing medical professionals and healthcare providers agree.

The American College of Obstetricians and Gynecologists has said acetaminophen - the key substance in Tylenol - is one of the few options for women during pregnancy to treat discomfort and fever, which can create major wellness concerns if ignored.

"In over twenty years of studies on the consumption of paracetamol in pregnancy, not a single reputable study has definitively established that the use of paracetamol in any stage of pregnancy leads to neurodevelopmental disorders in children," the organization stated.

The court filing mentions latest statements from the previous government in claiming the drug is reportedly hazardous.

In recent weeks, Trump caused concern from medical authorities when he told women during pregnancy to "struggle intensely" not to use Tylenol when unwell.

The FDA then released a statement that medical professionals should consider limiting the usage of Tylenol, while also mentioning that "a direct connection" between the drug and autism spectrum disorder in children has remains unverified.

The Health Department head Kennedy, who supervises the Food and Drug Administration, had pledged in April to conduct "extensive scientific investigation" that would identify the source of autism spectrum disorder in a matter of months.

But specialists cautioned that finding a unique factor of autism - thought by researchers to be the consequence of a complex mix of inherited and surrounding conditions - would prove challenging.

Autism spectrum disorder is a type of enduring cognitive variation and condition that affects how individuals perceive and relate to the world, and is diagnosed using doctors' observations.

In his lawsuit, the attorney general - who supports Trump who is campaigning for the Senate - alleges the manufacturer and J&J "willfully ignored and attempted to silence the research" around paracetamol and autism spectrum disorder.

This legal action seeks to make the companies "remove any promotional materials" that states Tylenol is secure for expectant mothers.

This legal action mirrors the complaints of a group of guardians of minors with autism and ADHD who filed suit against the producers of acetaminophen in two years ago.

A federal judge dismissed the lawsuit, saying research from the plaintiffs' authorities was inconclusive.

Ashley Carter
Ashley Carter

Elara is a seasoned writer and digital nomad who shares her adventures and expertise in lifestyle and technology.